Human IgG Levels as Indicators of EBV-Associated Lymphoma in Mice
Author Information
Author(s): Tang Yunlian, He Rongfang, Zhang Yang, Liu Fang, Cheng Ailan, Wu Yimou, Gan Runliang
Primary Institution: Cancer Research Institute, University of South China
Hypothesis
The study aims to evaluate the association between human IgG concentration and EBV-associated lymphoma development in hu-PBL/SCID mice.
Conclusion
The study found that increasing levels of human-derived IgG in peripheral blood from hu-PBL/SCID mice could be used to monitor EBV-related human B-cell lymphoma development.
Supporting Evidence
- 72% of the mice developed tumors after receiving human immune cells.
- Human IgG levels increased in mice as tumors developed.
- All induced tumors were confirmed to be human B-cell lymphomas.
Takeaway
The researchers found that when they put human immune cells into special mice, the mice got tumors, and the amount of a specific protein (IgG) in their blood went up as the tumors grew.
Methodology
Human peripheral blood lymphocytes from EBV-seropositive donors were injected into SCID mice, and IgG levels were measured over time.
Limitations
The study was limited to a small sample size of 12 mice for IgG measurement and may not fully represent all cases of EBV-associated lymphoma.
Participant Demographics
12 healthy adult donors provided peripheral blood lymphocytes.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website